| AML | Acute myeloid leukemia |
| ASO | Antisense oligonucleotides |
| ATR | Ataxia telangiectasia and Rad3-related protein |
| B-NHL | B-cell non-Hodgkin lymphoma |
| BP | Branch point |
| CLK | CDC2-like kinase |
| CLL | Chronic lymphocytic leukemia |
| CP | Cleavage and polyadenylation |
| EJCs | Exon junction complexes |
| ESEs | Exonic splicing enhancers |
| ESSs | Exonic splicing silencers |
| HCC | Hepatocellular carcinoma |
| hnRNPs | Heterogeneous nuclear ribonucleoproteins |
| ISEs | Intronic splicing enhancers |
| ISSs | Intronic splicing silencers |
| MB | Medulloblastoma |
| MDS | Myelodysplastic syndrome |
| METTL3 | N6-adenosine methyltransferase |
| NMD | Nonsense-mediated mRNA decay |
| PC | Pancreatic adenocarcinoma |
| PPT | Polypyrimidine tract |
| PTCs | Premature termination codons |
| PRMT5 | Protein arginine N-methyltransferase 5 |
| PKM | Pyruvate kinase |
| RNPs | Ribonucleoproteins |
| RRM | RNA-recognition motif |
| SRPK | SR protein kinase family |
| snRNPs | Small nuclear ribonucleoproteins |
| SS | Splice site |